Drug Makers, Public Health Groups Call On Congress To Adopt Incentives To Encourage Antibiotic R&D
CIDRAP News: Letter urges Congressional action to stimulate antibiotic development
“A coalition of drug makers, infectious disease experts, and public health advocates [Tuesday] called on U.S. lawmakers to pass measures that could ‘jumpstart’ the development of critically needed antibiotics. In a letter sent to lawmakers in the Senate and the House of Representatives, stakeholders from large and small pharmaceutical companies and organizations including the Infectious Diseases Society of America, the Pew Charitable Trusts, and Trust for America’s Health asked Congress to ‘swiftly enact a package of incentives that would sustainably reinvigorate the pipeline of antibiotics while ensuring patient access and appropriate stewardship’…” (Dall, 2/6).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.